On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...